Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
GWASCAT |
Pleiotropic Meta-Analysis of Cognition, Education, and Schizophrenia Differentiates Roles of Early Neurodevelopmental and Adult Synaptic Pathways.
|
31374203 |
2019 |
Schizophrenia
|
0.700 |
Biomarker
|
disease |
BEFREE |
Shank3, a postsynaptic scaffolding protein involved in regulating excitatory synapse assembly and function, has been implicated in several brain disorders, including autism spectrum disorders (ASD), Phelan-McDermid syndrome, schizophrenia, intellectual disability, and mania.
|
31275112 |
2019 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
De novo mutations (DNMs) of SHANK3 were subsequently identified in patients with several neurodevelopmental disorders, including autism spectrum disorders (ASDs), schizophrenia (SCZ), a Rett syndrome-like phenotype, and intellectual disability (ID).
|
30537371 |
2018 |
Schizophrenia
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
Mutations or altered protein levels of SHANK3 are implicated in neurodevelopmental disorders such as Phelan-McDermid syndrome, autism spectrum disorders, and schizophrenia (Guilmatre et al., 2014).
|
29735556 |
2018 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
To investigate whether variants in the SHANK3 gene contribute to the etiology of SCZ, we sequenced SHANK3 in 500 affected individuals (cohort C1).
|
28371232 |
2017 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
In this "<i>Perspectives</i>" article, we review and comment on current advances in Shank3 research and include some original data that show common Shank3 deficits in a number of seemingly unrelated human neurological disorders that include sporadic Alzheimer's disease (AD), autism spectrum disorder (ASD), bipolar disorder (BD), Phelan-McDermid syndrome (PMS; 22q13.3 deletion syndrome), and schizophrenia (SZ).
|
29321759 |
2017 |
Schizophrenia
|
0.700 |
Biomarker
|
disease |
BEFREE |
To characterize the zinc-induced Shank3 interactome, we performed various bioinformatic analyses that revealed significant associations of the interactome with subcellular compartments, including mitochondria, and brain disorders, such as bipolar disorder and schizophrenia.
|
29111324 |
2017 |
Schizophrenia
|
0.700 |
Biomarker
|
disease |
MGD |
We characterized two lines of mutant mice with Shank3 mutations linked to ASD and schizophrenia.
|
26687841 |
2016 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
We conclude that miR-7 binds to 3-prime untranslated regions of SHANK3 mRNA and causes the alteration of neuronal morphology and function, potentially playing a crucial role in the pathophysiological process of schizophrenia.
|
25882257 |
2015 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The SHANK3 gene encoding core scaffolding proteins at glutamatergic postsynapse is a typical dosage-sensitive gene, both deletions and duplications of which are associated with Phelan-McDermid syndrome, autism spectrum disorders, bipolar disorder, intellectual disability, or schizophrenia.
|
26572867 |
2015 |
Schizophrenia
|
0.700 |
Biomarker
|
disease |
BEFREE |
SHANK3 has been described in the Phelan-McDermid syndrome (PMS), but also in autism spectrum disorders (ASD) and schizophrenia associated to moderate to severe intellectual disability (ID) and poor language.
|
24124131 |
2014 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Rare mutations in SHANK3 have been associated with idiopathic ASDs, non-syndromic intellectual disability, and schizophrenia.
|
24132240 |
2013 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Genetic mutations of SHANK3 have been reported in patients with intellectual disability, autism spectrum disorder (ASD) and schizophrenia.
|
21606927 |
2012 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Recently, two de novo mutations in SHANK3 were described in schizophrenia patients.
|
21901269 |
2012 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
As mutations in SHANK3 were previously reported in autism, the occurrence of SHANK3 mutations in subjects with a schizophrenia phenotype suggests a molecular genetic link between these two neurodevelopmental disorders.
|
20385823 |
2010 |
Schizophrenia
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Schizophrenia
|
0.700 |
Biomarker
|
disease |
HPO |
|
|
|